Analysts surveyed by FactSet are expecting adjusted earnings of 75 cents per share on revenue of $3.86 billion. During the same quarter last year, the consumer products company earned 73 cents per diluted share on revenue of $3.90 billion.
Investors are most interested in: the company's 2017 outlook, the impact of demonetization in India, which is 4% of sales, and plans for reviving the North America Hill's pet nutrition business, according to Barclays analysts.
"Regarding management's 2017 outlook, recall last quarter, Colgate discussed aspirations for organic double-digit earnings growth but with the recent deterioration in the global currency environment, we'd expect a more measured stance," the analysts wrote in a recent note.
Barclays is modeling 4.7% organic sales growth and earnings per share to increase 6% in 2017.
The analysts said the Hill's pet nutrition unit should report the weakest growth as the company manages through distribution issues in North America. Last quarter, the delisting at a pet superstore and the ongoing shift to e-commerce, where Colgate is relatively underdeveloped vs. other channels, drove softer trends in North America.
"While the company has pegged mid-2017 as the time frame for a recovery in business trends, we'll look out for incremental updates on how plans are tracking," the firm said.
Shares of Colgate were largely flat at $68.04 in mid-afternoon trading today.